These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25782465)

  • 1. Response to letter regarding article, "fibroblast growth factor 23 and risk of incident stroke in community-living adults".
    Gutiérrez OM
    Stroke; 2015 May; 46(5):e124. PubMed ID: 25782465
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Zou and Zheng regarding article, "fibroblast growth factor 23 and risk of incident stroke in community-living adults".
    Zou L; Zheng S
    Stroke; 2015 May; 46(5):e123. PubMed ID: 25782467
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
    Panwar B; Jenny NS; Howard VJ; Wadley VG; Muntner P; Kissela BM; Judd SE; Gutiérrez OM
    Stroke; 2015 Feb; 46(2):322-8. PubMed ID: 25563643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study.
    di Giuseppe R; Kühn T; Hirche F; Buijsse B; Dierkes J; Fritsche A; Kaaks R; Boeing H; Stangl GI; Weikert C
    Eur J Epidemiol; 2015 Feb; 30(2):131-41. PubMed ID: 25527370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Serum Fibroblast Growth Factor-23 Levels and the Risk of Stroke and Its Subtypes: Evidence From a Meta-Analysis of Prospective Studies.
    Yao XY; Li S; Zhang LG; Liu ZH; Bao JN; Wu ZY
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3076-3083. PubMed ID: 30077605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated fibroblast growth factor-23 and risk of cardiovascular disease or mortality in the general population: A meta-analysis.
    Jiang M; Gong D; Fan Y
    Int J Cardiol; 2016 Nov; 222():342-345. PubMed ID: 27500761
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk.
    Zittermann A; Morshuis M; Kuhn J; Pilz S; Ernst JB; Oezpeker C; Dreier J; Knabbe C; Gummert JF; Milting H
    Eur J Nutr; 2016 Feb; 55(1):305-13. PubMed ID: 25657014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
    Isakova T; Craven TE; Lee J; Scialla JJ; Xie H; Wahl P; Marcovina SM; Byington RP; Wolf M
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):29-38. PubMed ID: 25343949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to letter regarding article, "Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis".
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Humphries KH; Tu JV; Behlouli H; Guo H; Pilote L
    Circulation; 2014 Dec; 130(25):e428-9. PubMed ID: 25539527
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study.
    Fyfe-Johnson AL; Alonso A; Selvin E; Bower JK; Pankow JS; Agarwal SK; Lutsey PL
    J Hypertens; 2016 Jul; 34(7):1266-72. PubMed ID: 27100793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of plasma factor XI with incident stroke and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Folsom AR; George KM; Appiah D
    Atherosclerosis; 2015 Nov; 243(1):181-5. PubMed ID: 26386215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter by Qureshi et al regarding article, "Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis".
    Qureshi W; Alirhayim Z; Khalid F
    Circulation; 2014 Dec; 130(25):e427. PubMed ID: 25539526
    [No Abstract]   [Full Text] [Related]  

  • 13. Intact fibroblast growth factor-23 in plasma from Gambian children: response to the letter from Smith et al.
    Braithwaite V; Bruggraber SF; Prentice A
    Osteoporos Int; 2013 Jun; 24(6):1935-6. PubMed ID: 23288027
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.
    Ong KL; Januszewski AS; O'Connell R; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Hung WT; Scott RS; Taskinen MR; Keech AC; Rye KA
    Diabetologia; 2015 Mar; 58(3):464-73. PubMed ID: 25425220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 23 and Incidence of Subarachnoid Hemorrhage: Nested Case-Control Study.
    Söderholm M; Engström G
    Stroke; 2015 Nov; 46(11):3260-2. PubMed ID: 26396029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response by Gutiérrez et al to Letter Regarding Article, "Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults".
    Gutiérrez OM; Panwar B; Judd SE
    Stroke; 2016 Nov; 47(11):e260. PubMed ID: 27758949
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.
    Shah NH; Dong C; Elkind MS; Sacco RL; Mendez AJ; Hudson BI; Silverberg S; Wolf M; Rundek T; Wright CB
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2048-53. PubMed ID: 26112008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community.
    Ratanapo S; Srivali N; Kittanamongkolchai W; Leeaphorn N; Ahmed S; Cheungpasitporn W; Chongnarungsin D
    Kidney Int; 2013 Sep; 84(3):621. PubMed ID: 23989361
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia.
    Kawarazaki H; Shibagaki Y; Shimizu H; Kawarazaki W; Ito N; Ishikawa A; Fukumoto S; Fujita T
    Clin Exp Nephrol; 2007 Sep; 11(3):255-257. PubMed ID: 17891358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults.
    Semba RD; Crasto C; Strait J; Sun K; Schaumberg DA; Ferrucci L
    J Hum Hypertens; 2013 Jun; 27(6):397-9. PubMed ID: 23190795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.